PYC Therapeutics (ASX:PYC) has announced it plans to progress investigational drug candidate PYC-002 into human clinical trials for Phelan-McDermid Syndrome. …
PYC nominates fourth clinical drug candidate in Phelan-McDermid program
December 16, 2024 Australian Biotech
Latest Video
New Stories
-
PYC nominates fourth clinical drug candidate in Phelan-McDermid program
December 16, 2024 - - Australian Biotech -
Immutep and Monash announce first publication detailing how human LAG-3 Binds to MHC Class II
December 16, 2024 - - Australian Biotech -
'They intended to launch a product on the market when that was not their intention'
December 16, 2024 - - BioPharma -
'The demand has been higher than expected, and we’ve worked hard to make sure that it remains affordable'
December 16, 2024 - - Latest News -
Auditor General set to table long-awaited PBS performance audit
December 15, 2024 - - Latest News -
The 'Week in Review' Podcast - 13 December
December 13, 2024 - - Podcast -
Report shows that weight is now the leading risk factor for Australia's disease burden
December 13, 2024 - - Latest News